Diabetes (Type 1)



Carbohydrate Content in the Diet in Type 1 Diabetes


Condition:   Diabetes Mellitus, Type 1
Interventions:   Other: Moderate carbohydrate diet;   Other: Higher carbohydrate diet
Sponsor:   Vastra Gotaland Region
Recruiting


Impact of the Continuous Measurement of Blood Glucose on Insulin Pump on Child Quality of Life With Type 1 Diabetes


Condition:   Type1diabetes
Interventions:   Behavioral: Peds QL questionnaire and diabetes modulate;   Behavioral: WHO-5 questionnaire;   Behavioral: Felt questionnaire
Sponsor:   Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Active, not recruiting


Group Education Curriculum for Older Teens With Type 1 Diabetes


Condition:   Type 1 Diabetes Mellitus
Intervention:   Behavioral: Intervention
Sponsor:   Boston Children’s Hospital
Recruiting


Physical Activity Monitoring Paediatric Type 1 Diabetes


Condition:   Diabetes Mellitus, Type 1
Intervention:   Behavioral: physical activity monitor and feedback
Sponsors:   Sheffield Hallam University;   Sheffield Children's Hospital NHS Foundation Trust
Not yet recruiting


Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus


Condition:   Diabetes Mellitus, Type 1
Interventions:   Dietary Supplement: Coenzyme Q10;   Drug: Insulin
Sponsor:   Ain Shams University
Active, not recruiting


Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Drug: Ergocalciferol;   Other: Placebo
Sponsor:   University of Massachusetts, Worcester
Recruiting


Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Device: CGMS Device;   Other: No Device
Sponsor:   New York University School of Medicine
Enrolling by invitation


Sleep, Coping and Executive Functioning in Youth With Type 1 Diabetes


Condition:   Diabetes Mellitus, Type 1
Intervention:   Other: No intervention
Sponsor:   Yale University
Enrolling by invitation


Incretin-based Therapy in Early Diagnosed Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Drug: Victoza® (liraglutide);   Drug: Placebo
Sponsors:   University of Oulu;   Oulu University Hospital;   Tampere University Hospital;   Turku University Hospital;   Skane University Hospital
Enrolling by invitation


A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus


Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: ipragliflozin;   Drug: Placebo;   Other: Insulin Therapy
Sponsor:   Astellas Pharma Inc
Active, not recruiting


Incretin-based Therapy in Late Preclinical Type 1 Diabetes


Condition:   Type 1 Diabetes
Interventions:   Drug: Victoza®;   Drug: Placebo
Sponsors:   University of Oulu;   Oulu University Hospital;   Tampere University Hospital;   Turku University Hospital;   Skane University Hospital
Enrolling by invitation


A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes


Condition:   Diabetes Mellitus, Insulin-Dependent
Interventions:   Drug: Ladarixin;   Drug: Placebo
Sponsor:   Dompé Farmaceutici S.p.A
Recruiting


Gene-virus Interactions Implicated in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Genetic: Enterovirus vaccination
Sponsor:   Hospices Civils de Lyon
Not yet recruiting


Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Drug: Siltuximab
Sponsors:   Carla Greembaum, MD;   Janssen Research & Development, LLC
Completed


Young With Diabetes Type 1 - Test of an mHealth App


Condition:   Diabetes Mellitus, Type 1
Intervention:   Device: Young with Diabetes - app
Sponsors:   Nordsjaellands Hospital;   Herlev Hospital;   Steno Diabetes Center;   Zealand University Hospital
Completed


Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults


Condition:   Type 1 Diabetes
Interventions:   Drug: Victoza®;   Drug: Placebo
Sponsors:   University of Oulu;   Oulu University Hospital;   Tampere University Hospital;   Turku University Hospital
Enrolling by invitation


The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With Type 1 Diabetes Mellitus (T1DM)


Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Dapagliflozin 5 mg;   Drug: Dapagliflozin 10mg
Sponsor:   AstraZeneca
Completed


Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus


Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: Albiglutide weekly injection;   Biological: Placebo weekly injection;   Biological: Insulin
Sponsor:   GlaxoSmithKline
Completed


Pancreas Volume in Preclinical Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Procedure: MRI, US, and blood samples
Sponsors:   University of Florida;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting


ATG-GCSF in New Onset Type 1 Diabetes


Condition:   Diabetes Mellitus, Type 1
Interventions:   Drug: Anti-Thymocyte Globulin (ATG);   Drug: Granulocyte colony stimulating factor (GCSF);   Drug: Placebo (for ATG);   Drug: Placebo (for GCSF)
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Center for Research Resources (NCRR);   Juvenile Diabetes Research Foundation;   American Diabetes Association;   Sanofi;   The Leona M. and Harry B. Helmsley Charitable Trust;   Amgen
Active, not recruiting


Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes


Condition:   Type 1 Diabetes Mellitus
Interventions:   Behavioral: 'KnowIt';   Behavioral: 'OnTrack'
Sponsors:   University of California, San Francisco;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting


Telemedicine for Adolescents With Insulin-dependent Diabetes


Condition:   Type 1 Diabetes
Interventions:   Other: Telemedicine;   Other: Control
Sponsor:   Texas Tech University Health Sciences Center
Active, not recruiting


Islet Allotransplantation in Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Drug: Human Pancreatic Islets
Sponsor:   Ohio State University
Enrolling by invitation


Imaging of Type 1 Diabetes Progression


Condition:   Type 1 Diabetes
Intervention:   Drug: ferumoxytol
Sponsors:   Jason Gaglia;   National Institute of Allergy and Infectious Diseases (NIAID);   Harvard Medical School
Active, not recruiting


Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes


Condition:   Type 1 Diabetes
Intervention:   Other: Transition Coordinator
Sponsors:   University of Western Ontario, Canada;   Juvenile Diabetes Research Foundation
Active, not recruiting

Refine Your Search Advanced Search